OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology.
Deep Dive Into Varonis Systems Stock: Analyst Perspectives (8 Ratings)In the last three months, 16 analysts have published ratings on Accenture ACN , offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 7 4 0 0 Last 30D 0 1 0 0 0 1M Ago 1 2 1 0 0 2M Ago 0 0 0 0 0 3M Ago 4 4 3 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $395.25, a high estimate of $429.00, and a low estimate of $360.00. Witnessing a positive shift, the current average has risen by 7.1% from the previous average price target of $369.06. Investigating Analyst Ratings: An Elaborate Study A clear picture of Accenture's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Arvind Ramnani Piper Sandler Raises Overweight $429.00 $422.00 Tien-Tsin Huang JP Morgan Raises Overweight $396.00 $370.00 Arvind Ramnani Piper Sandler Raises Overweight $422.00 $395.00 James Schneider Goldman Sachs Raises Buy $420.00 $370.00 David Koning Baird Maintains Neutral $370.00 $370.00 Ramsey El-Assal Barclays Raises Overweight $415.00 $350.00 Bryan Bergin TD Cowen Raises Buy $400.00 $321.00 Kevin Mcveigh UBS Raises Buy $415.00 $400.00 Jonathan Lee Guggenheim Raises Buy $395.00 $380.00 Keith Bachman BMO Capital Raises Market Perform $390.00 $380.00 Daniel Perlin RBC Capital Raises Outperform $389.00 $377.00 James Friedman Susquehanna Raises Neutral $360.00 $350.00 Jason Kupferberg B of A Securities Raises Buy $388.00 $365.00 David Koning Baird Raises Neutral $370.00 $350.00 Arvind Ramnani Piper Sandler Raises Overweight $395.00 $329.00 Tien-Tsin Huang JP Morgan Lowers Overweight $370.00 $376.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Accenture. This offers insight into analysts' perspectives on the current state of the company. Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Accenture compared to the broader market. Price Targets: Analysts predict movements in price targets, offering estimates for Accenture's future value. Examining the current and prior targets offers insights into analysts' evolving expectations. To gain a panoramic view of Accenture's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table. Stay up to date on Accenture analyst ratings. Discovering Accenture: A Closer Look Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries. Accenture's Economic Impact: An Analysis Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence. Revenue Growth: Accenture's remarkable performance in 3 months is evident. As of 31 August, 2024, the company achieved an impressive revenue growth rate of 2.63% . This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector. Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 10.27%, the company showcases strong profitability and effective cost control. Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.01%, the company showcases effective utilization of equity capital. Return on Assets (ROA): Accenture's ROA excels beyond industry benchmarks, reaching 3.06% . This signifies efficient management of assets and strong financial health. Debt Management: Accenture's debt-to-equity ratio is below the industry average. With a ratio of 0.15 , the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors. How Are Analyst Ratings Determined? Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are. Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update. Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors. Which Stocks Are Analysts Recommending Now? Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market . This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.In a shocking incident that has sent ripples through the tech world and raised serious questions about the reliability of artificial intelligence, Apple’s new AI-powered feature, “Apple Intelligence,” generated a false news alert claiming that Luigi Mangione, the suspect in the murder of UnitedHealthcare CEO Brian Thompson, had shot himself. This erroneous alert, falsely attributed to BBC News, has sparked widespread calls for the feature to be banned, with concerns ranging from the spread of misinformation to the potential for real-world harm. The incident occurred on December 15, 2024, when Apple Intelligence , designed to summarize and deliver news updates to users, pushed a notification to subscribers in the UK stating, “Luigi Mangione shoots himself.” This was categorically false. Mangione, who is currently awaiting extradition to New York to face murder charges, has not harmed himself. The false alert was delivered alongside two other accurate news summaries, further highlighting the unpredictable nature of the AI’s error. This incident is not the first time Apple Intelligence has misfired. Previously, the AI misrepresented a New York Times story about Israeli Prime Minister Benjamin Netanyahu, further fueling concerns about its accuracy and reliability. The Luigi Mangione incident, however, has amplified these concerns due to the severity of the misinformation and its potential impact on an ongoing criminal case. The Fallout: A Call for Accountability and a Ban The false alert has drawn sharp criticism from various quarters, including media organizations, AI experts, and the public. Reporters Without Borders (RSF), a non-profit organization advocating for press freedom, has called for an outright ban of the Apple Intelligence summary feature, stating that “generative AI services are still too immature to produce reliable information for the public, and should not be allowed on the market for such uses.” The BBC, falsely attributed as the source of the misinformation, has lodged a formal complaint with Apple, demanding immediate action to rectify the issue and prevent further occurrences. This incident underscores the potential damage that AI-generated misinformation can inflict on the credibility of news organizations and the public’s trust in information. The Dangers of AI-Generated Misinformation The Luigi Mangione case highlights the inherent dangers of relying on AI to curate and deliver news. While AI has the potential to personalize and streamline information consumption, its tendency to generate inaccurate or misleading content poses a significant threat. The Need for Regulation and Ethical AI Development The incident has reignited the debate surrounding the need for stricter regulation of AI technology. Experts argue that AI developers must prioritize accuracy and ethical considerations to prevent the spread of misinformation. My Perspective: As someone who closely follows technological advancements and their societal implications, I find the Luigi Mangione incident deeply concerning. While I appreciate the potential of AI to enhance our lives, this case serves as a stark reminder of the urgent need for responsible AI development and deployment. I believe that a temporary ban on the Apple Intelligence summary feature is warranted until Apple can demonstrate that it has implemented adequate safeguards to prevent the generation and dissemination of misinformation. Furthermore, this incident should serve as a wake-up call for the tech industry as a whole to prioritize ethical considerations and prioritize accuracy in AI development. The Future of AI and News The controversy surrounding Apple Intelligence raises important questions about the future of AI in news delivery and consumption. While AI can undoubtedly play a role in personalizing news experiences and filtering information overload , it is crucial to strike a balance between innovation and responsibility. Moving forward, it is imperative for tech companies, media organizations, and regulators to collaborate and establish clear guidelines for the ethical development and deployment of AI in the news industry. This will ensure that AI serves as a tool for enhancing information access and accuracy, rather than a source of misinformation and harm.
Lark Hotels Forms Joint Venture With Life House, Adding More Than 50 Properties to North American PortfolioMan United's clash at Ipswich is halted due to a fire alarm 110 miles away at Stockley Park - with VAR going down just before Ruben Amorim concedes the FIRST goal of his Red Devils reign
WASHINGTON — Century-old department store Nordstrom has agreed to be acquired and taken private by Nordstrom family members and a Mexican retail group in a $6.25 billion deal with the industry being squeezed by discount chains and other competition. Public companies are under a lot more scrutiny and if private, the Nordstrom may have more leeway in reviving a department store chain that has been attempting to reinvigorate sales for years. Nordstrom shareholders will receive $24.25 in cash for each share of Nordstrom common stock, or about $4 billion in all, representing a 42% premium on the company's stock as of March 18, when reports of a potential transaction was reported by the media. The acquiring group will also pick up more than $2 billion in Nordstrom debt. The traditional department stores have suffered in the face of withering competition from giants like Walmart and Target, as well as a host of fast-fashion bands and Amazon.com. Nordstrom rivals Macy's and Kohl's have been pressured by major investors to make huge changes in order to return more profit to shareholders. Sales at Nordstrom have essentially flatlined over the past decade or so and it announced last year that it was closing all of its Canadian stores and cutting 2,500 jobs as it winds down operations in the country. Nordstrom first announced plans to expand to Canada in 2012 and opened its first store in Calgary at CF Chinook Centre in September 2014. The offer announced Monday tops the previous $23-per-share bid that the Nordstrom family and Mexican retail group, El Puerto de Liverpool, made in September. The board also plans to authorize a special dividend of up to 25 cents per share, based on Nordstrom’s cash on hand immediately prior to and contingent on the close of the transaction. The deal is expected to close in the first half of 2025, at which time the company's shares will no longer trade publicly. “While a change in ownership does not automatically remedy all of the problems with the department store operation, it will allow the family and their backers to take a long-term view of the business and make necessary investments and changes away from the short-term scrutiny of public markets,” wrote Neil Saunders, Managing Director of GlobalData, in a note to clients. Nordstrom’s board of directors unanimously approved the the proposed transaction, with members Erik and Pete Nordstrom, part of the Nordstrom family taking over the company — recusing themselves from that vote. Following the close of the transaction, the Nordstrom family will have a majority ownership stake in the company. Erik and Pete Nordstrom are the fourth-generation leadership at the Seattle retailer, which was founded in 1901 as a shoe store. Erik is the company’s chief executive and Peter is president. After opening 23 new stores so far this year, the company now operates a combined 381 Nordstrom and Nordstrom Rack stores in the U.S. Nordstrom shares fell about 1.5% Monday, but they are up 34% this year on rumors of a family takeover. The company's stock is still down considerably from post-pandemic highs above $40 per share. In May of this year, Bruce Nordstrom, a retail executive who helped expand his family’s Pacific Northwest department store chain into an upscale national brand, died at age 90 . He was one of several Nordstrom family members who in 2017 made a push to take the company private, proposing to buy out the 70% of the department store’s stock they didn’t already own. Those talks failed in 2018 but earlier this year, his sons started another series of buyout negotiations , leading to Monday's announcement.December 23, 2024 This article has been reviewed according to Science X's editorial process and policies . Editors have highlightedthe following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread by Anika Hazra, University of Toronto A team led by researchers at the University of Toronto has created a platform, called SIMPL2, that improves the study of protein-protein interactions by simplifying detection while improving measurement accuracy. Interactions between proteins play a significant role in biological processes, including those involved in disease. The team behind the SIMPL2 platform designed it to optimize researchers' ability to measure protein-protein interactions for targeted drug therapies. While protein-protein interactions have previously been considered 'undruggable' using small molecules , the platform addresses this challenge by facilitating the measurement of these interactions—improving our understanding of the types of molecules needed to control them. "Many methods have been developed to measure interactions between proteins, especially more recently as the significance of protein interactions in disease has become more apparent," said Zhong Yao, first author on the study and senior research associate of U of T's Donnelly Centre for Cellular and Biomolecular Research. "However, all of these methods have shortcomings, including high costs and complicated procedures that delay results. The biggest advantages of our SIMPL2 platform are that it produces more reliable measurements and is comparatively cheaper to use." The study was published recently in the journal Molecular Systems Biology . Yao started working on the protein interaction measurement problem while developing the original SIMPL (Split-Intein Medicated Protein Ligation) system . SIMPL2 is an update of SIMPL that involves the use of the split luciferase enzyme for detection of protein interactions through luminescence. In addition to improving identification of interactions, the entire measurement process occurs through one medium: liquid. This simplifies the process considerably by reducing the number of steps required to carry out measurements. "One of the issues with SIMPL was that we had to use an additional process, called ELISA, to identify the proteins spliced by the SIMPL platform," said Yao. "It was a painful process that made an otherwise effective technology more complicated and expensive to use than it needed to be. SIMPL2 only requires one step, which can be performed manually, or it can be automated for even more efficiency in high-throughput studies." To test the new platform's sensitivity and applicability, the research team used it to measure interactions between proteins affected by modulators. Protein modulators include molecules that inhibit interactions between proteins, those that facilitate protein interactions and those that facilitate the degradation of target proteins. SIMPL2 was found to perform well in identifying these interactions, even in cases where the interactions were weak. Discover the latest in science, tech, and space with over 100,000 subscribers who rely on Phys.org for daily insights. Sign up for our free newsletter and get updates on breakthroughs, innovations, and research that matter— daily or weekly . While quantum computers and AI have made it easier to design small molecules for drug therapies, this has led to a need to develop much faster methods for validating the efficacy of new drugs. SIMPL2 can meet that need, as it can be used to test interactions between new molecules and their target proteins in cultured human cells. It is also capable of keeping apace with the rate at which new molecules are being designed. "We designed SIMPL2 to be a universal method for studying protein interactions that is rapid and inexpensive, as well as highly sensitive," said Igor Stagljar, principal investigator on the study and professor of biochemistry at U of T's Temerty Faculty of Medicine. "Now that we have optimized the platform, our next step is to use it to study interactions that play key roles in diseases, like cancer, to learn how to develop drug therapies. This work will involve the use of quantum computers and AI in collaboration with Alán Aspuru-Guzik's lab at U of T and Insilico Medicine, a global leader in generative AI drug discovery." More information: Zhong Yao et al, A split intein and split luciferase-coupled system for detecting protein-protein interactions, Molecular Systems Biology (2024). DOI: 10.1038/s44320-024-00081-2 Journal information: Molecular Systems Biology Provided by University of Toronto